In vivo shRNA screens in solid tumors

Nature Protocols

Volumn 9, Issue 12, 2014, Pages 2880-2902

  Gargiulo, Gaetano ^a   Serresi, Michela ^a   Cesaroni, Matteo ^b   Hulsman, Danielle ^a   Van Lohuizen, Maarten ^a,c  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Cancer Genomics Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HIGH MOBILITY GROUP B3 PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL LOSS; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CTNNB1 GENE; DNA SEQUENCE; EGFR GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC TRANSFECTION; GENOTYPE; GLIOMA; HMGB GENE; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOLECULAR LIBRARY; MOUSE; NONHUMAN; RNA INTERFERENCE; RNA LIBRARY; RNA SYNTHESIS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; EXPERIMENTAL NEOPLASM; FEMALE; GENE LIBRARY; GENE TARGETING; GENETIC PROCEDURES; GENETICS; HUMAN; LUNG TUMOR; MALE; ONCOGENE; PROCEDURES; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; FEMALE; GENE LIBRARY; GENE TARGETING; GENETIC TECHNIQUES; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MALE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; ONCOGENES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84911466839     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2014.185     Document Type: Article

References (32)

1. Uren, A.G., Kool, J., Berns, A. & van Lohuizen, M. Retroviral insertional mutagenesis: past, present and future. Oncogene 24, 7656-7672 (2005).
2. Brummelkamp, T.R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247 (2002).
3. Zender, L. et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135, 852-864 (2008).
4. Bric, A. et al. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell 16, 324-335 (2009).
5. Meacham, C.E., Ho, E.E., Dubrovsky, E., Gertler, F.B. & Hemann, M.T. In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression. Nat. Genet. 41, 1133-1137 (2009).
6. Gargiulo G.,et al In vivo RNAi screen for BMI1 targets identifies TGF-?/BMP-ER stress pathways as key regulators of neural-And malignant glioma-stem cell homeostasis. Cancer Cell 23 660-676, 2013).
7. Xue, W. et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc. Natl. Acad. Sci. USA 109, 8212-8217 (2012).
8. Iorns, E. et al. Whole-genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor. Breast Cancer Res. Treat. 135, 79-91 (2012).
9. Miller, P.G. et al. In vivo RNAi screening identifies a leukemia-specific dependence on integrin-?3 signaling. Cancer Cell 24, 45-58 (2013).
10. Braun, C.J. & Hemann, M.T. Unraveling tumor suppressor networks with in vivo RNAi. Cell Stem Cell 12, 639-641 (2013).
11. O'Brien, C.A., Kreso, A. & Jamieson, C.H.M. Cancer stem cells and self-renewal. Clin. Cancer Res. 16, 3113-3120 (2010).
12. Magee, J.A., Piskounova, E. & Morrison, S.J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283-296 (2012).
13. Beronja, S. et al. RNAi screens in mice identify physiological regulators of oncogenic growth. Nature 501, 185-190 (2013).
14. Root, D.E., Hacohen, N., Hahn, W.C., Lander, E.S. & Sabatini, D.M. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat. Methods 3, 715-719 (2006).
15. Huang, S. et al. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell 15, 328-340 (2009).
16. Prahallad, A. et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature 483, 100-103 (2012).
17. Wuestefeld, T. et al. A direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration. Cell 153, 389-401 (2013).
18. Wang, T., Wei, J.J., Sabatini, D.M. & Lander, E.S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80-84 (2014).
19. Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84-87 (2014).
20. Du, J. et al. In vivo RNAi screen reveals neddylation genes as novel regulators of Hedgehog signaling. PLoS ONE 6, e24168 (2011).
21. Chen, T. et al. An RNA interference screen uncovers a new molecule in stem cell self-renewal and long-term regeneration. Nature 485, 104-108 (2012).
22. Kaelin, W.G. Molecular biology. Use and abuse of RNAi to study mammalian gene function. Science 337, 421-422 (2012).
23. Wilson, J.L., Hemann , M.T., Fraenkel, E. & Lauffenburger, D.A. Integrated network analyses for functional genomic studies in cancer. Semin. Cancer Biol. 23, 213-218 (2013).
24. Lee, D.-F. et al. Combining competition assays with genetic complementation strategies to dissect mouse embryonic stem cell self-renewal and pluripotency. Nat. Protoc. 7, 729-748 (2012).
25. Bruggeman, S.W.M. et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 12, 328-341 (2007).
26. Ellis, B.L., Potts, P. R. & Porteus, M.H. Creating higher titer lentivirus with caffeine. Hum. Gene Ther. 22, 93-100 (2011).
27. Kutner R.H.,Zhang X.-Y,Reiser J. Production concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 4, 495-505, 2009).
28. Baumann, B.C., Dorsey, J.F., Benci, J.L., Joh, D.Y. & Kao, G.D. Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme. J. Vis. Exp. 67, e4089 (2012).
29. Montini, E. et al. The genotoxic potential of retroviral vectors is st rongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest. 119, 964-975 (2009).
30. Zuber, J. et al. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat. Biotechnol. 29, 79-83 (2011).
31. Fellmann, C. et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 5, 1704-1713 (2013).
32. Wolf, J. et al. An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation. Oncogene 33, 4273-4278 (2013).